Ingrid Lunden / TechCrunch:
London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M — Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery.
